Cargando…
First person – David Pirovich
First Person is a series of interviews with the first authors of a selection of papers published in Biology Open (BiO), helping early-career researchers promote themselves alongside their papers. David Pirovich is first author on ‘Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase enhances...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104855/ http://dx.doi.org/10.1242/bio.051631 |
_version_ | 1783512299804295168 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Biology Open (BiO), helping early-career researchers promote themselves alongside their papers. David Pirovich is first author on ‘Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase enhances formation of the blood-clot lysis protein plasmin’, published in BiO. David is a PhD candidate in the lab of Dr Patrick Skelly at Tufts University, North Grafton, MA, USA, investigating novel moonlighting functions (thrombolysis, immunomodulation) of Schistosoma mansoni glycolytic enzymes. |
format | Online Article Text |
id | pubmed-7104855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-71048552020-03-31 First person – David Pirovich Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open (BiO), helping early-career researchers promote themselves alongside their papers. David Pirovich is first author on ‘Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase enhances formation of the blood-clot lysis protein plasmin’, published in BiO. David is a PhD candidate in the lab of Dr Patrick Skelly at Tufts University, North Grafton, MA, USA, investigating novel moonlighting functions (thrombolysis, immunomodulation) of Schistosoma mansoni glycolytic enzymes. The Company of Biologists Ltd 2020-03-24 /pmc/articles/PMC7104855/ http://dx.doi.org/10.1242/bio.051631 Text en © 2020. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – David Pirovich |
title | First person – David Pirovich |
title_full | First person – David Pirovich |
title_fullStr | First person – David Pirovich |
title_full_unstemmed | First person – David Pirovich |
title_short | First person – David Pirovich |
title_sort | first person – david pirovich |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104855/ http://dx.doi.org/10.1242/bio.051631 |